Učitavanje...
Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
We investigated whether circulating microparticles (MPs) could serve as prognostic biomarkers in non-small cell lung cancer (NSCLC) patients. We enrolled 25 control subjects and 136 NSCLC patients categorized into disease-progression (DP, n=42) and disease-control (DC, n=94) groups. Flow cytometric...
Spremljeno u:
Izdano u: | Oncotarget |
---|---|
Glavni autori: | , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Impact Journals LLC
2017
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652677/ https://ncbi.nlm.nih.gov/pubmed/29100283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18372 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|